Medical device manufacturer Stryker has agreed to a sizable settlement to provide compensation for individuals who received a Stryker Rejuvenate or Stryker ABG II Hip stem implant.
According to Market Watch, the company will be spending $1 billion to resolve claims from patients who had a Stryker hip implant implanted before November 3, 2014, at a U.S. hospital or qualifying military hospital. Patients who were forced to undergo a revision surgery are eligible to receive compensation. Those who suffered additional complications will also be provided with funding from the settlement money.
A dangerous drug attorney knows many claims arising from defective drugs and medical devices are resolved when the company pledges funds to settle complaints. Those who have been harmed by a defective hip implant product should consult with an attorney to learn whether they are eligible to receive compensation from the settlement or if they should pursue a different approach to recovering monetary damages for losses.
Stryker Settlement Reached for Hip Implant Problems
According to the terms of the settlement, there is no cap on the amount of money that will be paid out to patients who are affected by the defective Stryker implants. Patients can qualify provided they experienced certain problems, including:
- Pseudo-tumors resulting from metal pieces breaking off of the hip implants.
- Fluid in their joints
- Dissolution of the bone
- Necrosis of the tissue or bone
- Metal toxicity
- Hypersensitivity to metal products
- Inflammation of the synovial membrane
Patients who experience these complications typically need to have their hip implant device removed as the only means of correcting their health issues. Patients who underwent a revision surgery because of specific complications are eligible to recover compensation through the settlement. Patients are generally eligible to recover through the settlement assuming they underwent a revision surgery due to:
- An elevated cobalt blood test
- A diagnostic scan demonstrating abnormalities
- A pathological determination that tissue had been damaged
- An inter-operative determination that tissue had been damaged
Patients who qualify may be entitled to a base payment equal to $300,000 as a part of the recent settlement agreement. Those who had procedures performed on both hips using a Stryker Rejuvenate or Stryker ABG II hip stem should be entitled to receive a base minimum payment of as much as $600,000. If patients experienced additional complications, more funds may be available. For example, patients may be entitled to receive anywhere from an additional $10,000 to an additional $600,000 if they experienced additional health issues including:
- Infections after a revision surgery
- Multiple revision surgeries
- Dislocation of the hip
Those who can demonstrate lost wages can recover additional compensation through the settlement as well. In addition, health conditions such as diabetes, smoking or related medical problems will not reduce the amount of compensation that is available to patients who recover through the settlement.
Those who are eligible should speak with an attorney about how to make their settlement claim. An attorney can assist in determining whether you qualify for the settlement and can advise you on options that are available to you both if you are eligible and if you need to seek compensation through a different legal approach.
If you have been harmed, contact DeCarlo Law today at 877-572-0065 or visit http://www.decarlolaw.com/ to schedule a consultation.